Type I IFN receptor blockade by anifrolumab reduces cutaneous lupus in monogenic SLE.

IF 5.5 4区医学 Q1 DERMATOLOGY

Journal Der Deutschen Dermatologischen Gesellschaft Pub Date : 2025-06-26 DOI:10.1111/ddg.15806

Julian Steininger, Christine Wolf, Min Ae Lee-Kirsch, Claudia Günther

引用次数: 0

查看原文本刊更多论文

单克隆抗体阻断I型IFN受体可减少单基因SLE患者的皮肤红斑狼疮。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal Der Deutschen Dermatologischen Gesellschaft 医学-皮肤病学

CiteScore

3.50

自引率

25.00%

发文量

406

审稿时长

1 months

期刊介绍： The JDDG publishes scientific papers from a wide range of disciplines, such as dermatovenereology, allergology, phlebology, dermatosurgery, dermatooncology, and dermatohistopathology. Also in JDDG: information on medical training, continuing education, a calendar of events, book reviews and society announcements. Papers can be submitted in German or English language. In the print version, all articles are published in German. In the online version, all key articles are published in English.